This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

583 * Wed, 8/4/2010, 2:00 PM - 3:50 PM CC-117 (West)
Statistical Strategies for Oncology Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Aloka Chakravarty, FDA
2:05 PM Bias in Oncology Time-to-Event Data Analysis — Din Chen, Georgia Southern University ; Yuhlong Lio, The University of South Dakota ; Yibin Wang, Novartis
2:35 PM Exponential Failure-Time Mixture Model for Evaluating Efficacy in the Presence of a Biomarker: KRAS Validation — Kallappa M. Koti, FDA
2:50 PM Case Study: Benefits of an Adaptive Clinical Trial Design in Oncology — Darcy Hille, Merck & Co., Inc. ; Christine K. Gause, Merck Research Laboratories ; Jason B. Clark, Merck Research Laboratories ; Sarah Hoagey, Merck & Co., Inc. ; Keaven M. Anderson, Merck Research Laboratories
3:05 PM Drug Regimen Selection in Early-Stage Two-Arm Oncology Clinical Trials — Guohui Liu, Millennium Pharmaceuticals, Inc. ; Xuedong Chi, Millennium Pharmaceuticals, Inc.
3:20 PM Statistical Methods for a Phase II Oncology Trial with a GMI Endpoint — Stephanie Ann Kovalchik, University of California, Los Angeles ; William Leonard Mietlowski, Novartis Oncology
3:35 PM Sensitivity Analysis for PFS — Alicia Zhang, Amgen Inc. ; Alan Rong, Amgen Inc. ; Ying Tian, Amgen Inc. ; Michael Wolf, Amgen Inc.



2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.